Oncopharmpod
PERSEPHONE: Bonus Pod
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:13:17
- Mas informaciones
Informações:
Sinopsis
The release of ASCO's 2018 annual abstracts resulted in widespread media coverage of PERSEPHONE, the largest trial yet investigating 6 vs. 12 months of adjuvant trastuzumab in breast cancer. We get into the history of adjuvant trastuzumab studies and what to watch for going forward.
